NCT07084727 Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
| NCT ID | NCT07084727 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Antwerp |
| Condition | Endothelial Function (FMD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2025-11-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-07-01 with a primary completion date of 2025-11-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
Eligibility Criteria
Inclusion Criteria: * at least 18 years old * willing to undergo vascular assessments * informed consent signed Exclusion Criteria: * Unwilling to provide informed consent * Open-angle glaucoma * Epilepsia * (gestational) Diabetes * Multiple pregnancies * Fetal malformations * Hypercholesterolemia * Kidney disease * Auto-immune disorders * Connective tissue diseases
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07084727 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Endothelial Function (FMD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084727 currently recruiting?
Yes, NCT07084727 is actively recruiting participants. Contact the research team at studies.cardiologie@uza.be for enrollment information.
Where is the NCT07084727 trial being conducted?
This trial is being conducted at Edegem, Belgium.
Who is sponsoring the NCT07084727 clinical trial?
NCT07084727 is sponsored by University Hospital, Antwerp. The trial plans to enroll 60 participants.